Johnson & Johnson (
) will begin trading ex-dividend on August 22, 2014. A cash
dividend payment of $0.7 per share is scheduled to be paid on
September 09, 2014. Shareholders who purchased JNJ stock prior to
the ex-dividend date are eligible for the cash dividend payment.
This represents an 6.06% increase over the same period a year ago.
At the current stock price of $103.21, the dividend yield is
The previous trading day's last sale of JNJ was $103.21,
representing a -3.31% decrease from the 52 week high of $106.74 and
a 20.71% increase over the 52 week low of $85.50.
JNJ is a part of the Health Care sector, which includes
companies such as Novartis AG (
) and Pfizer, Inc. (
). JNJ's current earnings per share, an indicator of a company's
profitability, is $5.42. Zacks Investment Research reports JNJ's
forecasted earnings growth in 2014 as 7.2%, compared to an industry
average of .5%.
For more information on the declaration, record and payment
dates, visit the
has the full list of stocks that have an ex-dividend today.
Interested in gaining exposure to JNJ through an Exchange
Traded Fund [ETF]?
The following ETF(s) have JNJ as a top-10 holding:
- Select Sector SPDR Fund - Health Care (
- iShares Dow Jones U.S. Health Care Index Fund (
- Merrill Lynch Pharmaceutical HOLDRS (
- Vanguard Health Care ETF (
- iShares U.S. Pharmaceutical ETF (
The top-performing ETF of this group is VHT with an increase of
9.33% over the last 100 days. XLV has the highest percent weighting
of JNJ at 12.77%.